Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Gallenwege » Neoplasie 21. Dezember 2025
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Cholezystitis - Cholelithiasis
Neoplasie
Anderes
Leber
Magen-Darm
Oesophagus
Pankreas
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 849  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 16967  
   
Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials.
Cancer
Saj F, Namayanja FK, Xiao L, Borad MJ, Kelley RK, Goyal L, Azad NS, Bachini M, Lindsey S, Pant S, Valle JW, Fashoyin-Aje LA, Javle M.
PMID: 41417596 [PubMed - indexed for MEDLINE]


Efficacy and safety of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1/PD-L1 inhibitors versus systemic chemotherapy plus lenvatinib and PD-1/PD-L1 inhibitors in advanced unresectable cholangiocarcinoma: a retrospective cohort study.
Cancer Immunol Immunother
Zhang Z, Wang M, Chen G, Wu Y, Chen X, Guo X, Zhang B.
PMID: 41417116 [PubMed - indexed for MEDLINE]


Anti-gallbladder cancer activities and toxicity studies of glycyrrhetinic acid derivative as a novel PPARγ agonist.
Front Immunol
Liu M, Ma H, Xiong G, Qi M, Xia Y, Zhao Y, Ji C, Sun J, Sun T.
PMID: 41403929 [PubMed - indexed for MEDLINE]


Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY).
Ann Transplant
Kim SH, Hwang S, Kim BW, Joo DJ, Lee KW, Choi GS, Ryu JH, Kim DS, Choi D, Cho JY, You YK, Choi D, Kim TS, Park P.
PMID: 41399117 [PubMed - indexed for MEDLINE]


Metabolic collusion driving immune evasion in cholangiocarcinoma: unmasking the dual control of the immuno-metabolic microenvironment.
Front Immunol
Xue J, Zhang L, Zhang K, Wu Y, Zhou K, Lu X.
PMID: 41394868 [PubMed - indexed for MEDLINE]


Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response.
NPJ Syst Biol Appl
De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Tran Cao HS, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ.
PMID: 41387975 [PubMed - indexed for MEDLINE]


A review, evaluation and content mapping study of Australian patient-facing online pancreatobiliary cancer resources.
Support Care Cancer
Ferrar K, Baggoley C, Beatty L, Brooke-Smith M, Han CY, Holz B, Koczwara B, Lee J, Paterson C, Wallen MP, Robertson A, Barreto SG.
PMID: 41385087 [PubMed - indexed for MEDLINE]


Primary extra-gastrointestinal stromal tumor of the gallbladder: A case report.
World J Gastroenterol
Wang P, Zhu CR, Yao J, Xu P, Zhang K, Zhu J, Ge XY, Chen Y, Wang WZ.
PMID: 41378324 [PubMed - indexed for MEDLINE]


Tumors and tumor-like lesions of the gall bladder-A review.
Indian J Pathol Microbiol
Husain N, Shukla S, Srivastava P.
PMID: 41347612 [PubMed - indexed for MEDLINE]


The real-world clinical effectiveness of durvalumab in advanced biliary tract cancer: a mimic comparative analysis through survival data reconstruction.
Front Immunol
Ji HX, Si MH, Sun Z, Yang N, Chen Z.
PMID: 41341598 [PubMed - indexed for MEDLINE]


Clinical Efficacy and Safety of Gemcitabine-Cisplatin Combination in Metastatic Gallbladder Cancer: A Prospective Study from North India.
J Gastrointest Cancer
Dewan A, Talwar V, Goel V, Choudhary SK, Mehrotra K, Chugh S, Saha S, Basu DA, Mukherjee A, Bansal R, Jain A, Shivarudraiah SSM, Sharma M, Goel P, Saha R, Goyal S, Batra U, Patnaik N, Doval DC, Dewan AK.
PMID: 41335168 [PubMed - indexed for MEDLINE]


Surgical Outcomes and Postoperative Changes in Nutritional Indexes and Sarcopenia Markers in Oldest-old Patients With Resected Biliary Tract Cancer: A Retrospective Cohort Study.
Anticancer Res
Utsumi M, Inagaki M, Kitada K, Tokunaga N, Onoda N, Omoto K, Takahashi R, Okabayashi H, Hamano R, Miyaso H, Teraishi F, Tsunemitsu Y, Otsuka S.
PMID: 41318144 [PubMed - indexed for MEDLINE]


Oncological outcome after robot-assisted versus open pancreatoduodenectomy for upfront resectable cancer in the pancreatic head: a nationwide cohort analysis.
Br J Surg
Menso JE, Bruna CL, Ali M, Bonsing B, Bosscha K, Brosens LAA, Busch OR, Crobach ASLP, Daams F, Derksen W, Dewulf MJL, Doukas M, Fariña Sarasqueta A, Festen S, Abu Hilal M, de Hingh IHJT, Homs MYV, Kazemier G, Lips DJ, Luyer MDP, de Meijer VE, Mieog JSD, Te Riele WW, van Santvoort HC, van der Schelling GP, Stommel M, Verheij J, de Wilde RF, Wilmink JW, Molenaar IQ, Groot Koerkamp B, van der Geest LG, Besselink MG.
PMID: 41313602 [PubMed - indexed for MEDLINE]


Preoperative serum prealbumin as a prognostic marker for survival after gallbladder cancer resection: a multicenter study.
BMC Gastroenterol
Huang Z, Wang J, Zhou B, Liao R, Xu J, Guo P, Liu Z, You N, Tao R, Hu Q.
PMID: 41310485 [PubMed - indexed for MEDLINE]


Adenocarcinoma of the gallbladder: an incidental histopathological finding post-operative laparoscopic cholecystectomy in Saudi Arabia.
J Med Life
Saggaf AM, Nagi AM, Al Atat RM, Saggaf MO, Timraz JH, Thalib HI, Alkhateeb LM.
PMID: 41306949 [PubMed - indexed for MEDLINE]


Endoscopic Stenting for Unresectable Malignant Hilar Biliary Obstruction: Where Do We Stand Today? A Narrative Review.
Curr Oncol
Inoue T, Naitoh I, Yoshida M, Okumura F.
PMID: 41294670 [PubMed - indexed for MEDLINE]


Demystifying metabolic‒immune crosstalk: how amino acid metabolic reprogramming shapes the malignant phenotype and macrophage polarization of biliary and pancreatic tumors.
Int J Biol Sci
Zhang J, Chu Z, Li J, Xie L, Ding C, An Z, Wang X, Jin H, Zhang X, Liu Q, Yang J.
PMID: 41281760 [PubMed - indexed for MEDLINE]


LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers.
Future Oncol
Ikeda M, Wörns MA, Akce M, Hsu C, Tebbutt NC, Casadei-Gardini A, Sah J, Farid-Kapadia M, Stirnadel-Farrant HA, Paskow MJ, Baur B, Melillo G, Schmidt J, Daktera A, Knox JJ.
PMID: 41277677 [PubMed - indexed for MEDLINE]


Clinical and economic outcomes of adding durvalumab to gemcitabine/cisplatin in advanced biliary tract cancers: A multicenter descriptive study.
Clin Res Hepatol Gastroenterol
Luciani L, Carlier C, Leuk L, Clarenne J, Lepage V, Perrier M, Bouché O, Gigante E, Slimano F.
PMID: 41271098 [PubMed - indexed for MEDLINE]


Preoperative risk factors for early recurrence and relapse-free survival after R0 resection of gallbladder cancer.
Medicine (Baltimore)
Lee SH, Kim DU, Seol YM.
PMID: 41261638 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 16967    Seite 1 von 849  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1